Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/34433
Title: Age and follicular phase estradiol are better predictors of pregnancy outcome than luteinizing hormone in menotropin ovulation induction for anovulatory polycystic ovarian syndrome.
Authors: McCloud P.I.;McQuinn B.;Burger H.G.;Healy D.L.;Kovacs G.T.;McDonald J.;McClure N.
Institution: (McClure, McDonald, Kovacs, Healy, McCloud, McQuinn, Burger) Monash Medical Centre, Prince Henry's Inst. of Medical Res., 246 Clayton Road, Clayton, Vic. 3168, Australia
Issue Date: 25-Oct-2012
Copyright year: 1993
Publisher: Elsevier Inc. (360 Park Avenue South, New York NY 10010, United States)
Place of publication: United States
Publication information: Fertility and Sterility. 59 (4) (pp 729-733), 1993. Date of Publication: 1993.
Abstract: Objective: To examine the relationship of baseline and preovulatory serum E2, P, and LH levels and age with pregnancy outcome in polycystic ovarian syndrome (PCOS) patients undergoing hMG ovulation induction. Design(s): Retrospective analysis of all available data over 2 years. Setting(s): Tertiary referral ovulation induction clinic. Subjects: Forty-four anovulatory PCOS patients with 25 ovulatory nonconception and 50 conception cycles after hMG ovulation induction. Main Outcome Measure(s): Ovulation (midluteal serum P > 25 nmol/L [7.86 ng/mL]); pregnancy (serum beta-hCG > 30 mIU/mL 16 days after ovulating injection); pregnancy outcome: pregnancy termination < 20 weeks' or >=20 weeks' amenorrhea. Result(s): Of the endocrine parameters considered, none was significantly different in nonconceptive and conceptive ovulatory cycles. Miscarriage was associated with low basal serum E2: median value for pregnancies ending <20 weeks, 105 pmol/L (28.6 pg/mL) for >=20 weeks 150 pmol/L (40.9 pg/mL). It was also significantly associated with age. For patients > 29.5 years of age, (29.5 years, population mean age) a baseline E2 <= 140 pmol/L (38.2 pg/mL) had sensitivity 92%, specificity 54%, positive predictive value 65%, and negative predictive value 87% for the prediction of miscarriage. The nature of the previous cycle, the day of the cycle on which therapy commenced, and a past history of miscarriage were not related either to pregnancy outcome or to basal serum E2.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1016/S0015-0282(16)55850-6
PubMed URL: 8458487 [http://www.ncbi.nlm.nih.gov/pubmed/?term=8458487]
ISSN: 0015-0282
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/34433
Type: Article
Subjects: *chorionic gonadotropin/do [Drug Dose]
*chorionic gonadotropin/dt [Drug Therapy]
*chorionic gonadotropin/pd [Pharmacology]
*estradiol/ec [Endogenous Compound]
follitropin/ec [Endogenous Compound]
*human menopausal gonadotropin/ad [Drug Administration]
*human menopausal gonadotropin/do [Drug Dose]
*human menopausal gonadotropin/dt [Drug Therapy]
*luteinizing hormone/ec [Endogenous Compound]
prasterone sulfate/ec [Endogenous Compound]
*progesterone/ec [Endogenous Compound]
*anovulation/dt [Drug Therapy]
age
article
clinical article
echography
female
follicular phase
hormone blood level
human
intramuscular drug administration
ovary follicle
*ovary polycystic disease/di [Diagnosis]
*ovary polycystic disease/dt [Drug Therapy]
ovulation induction
prediction
*pregnancy
priority journal
radioimmunoassay
spontaneous abortion
*chorionic gonadotropin/ad [Drug Administration]
ovary follicle
*ovary polycystic disease / *diagnosis / *drug therapy
ovulation induction
prediction
*pregnancy
priority journal
*anovulation / *drug therapy
spontaneous abortion
age
radioimmunoassay
article
clinical article
echography
female
follicular phase
hormone blood level
human
intramuscular drug administration
Appears in Collections:Articles

Show full item record

Page view(s)

4
checked on Aug 18, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.